Apolipoprotein E isoforms and susceptibility to genetic generalized epilepsies

References

• Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for classification and terminology. Epilepsia. 2017;58(4):512–521.
   PubMed Web of Science ®Google Scholar
• Gallentine WB, Mikati MA. Genetic generalized epilepsies. J Clin Neurophysiol. 2012;29(5):408–419.
   PubMed Web of Science ®Google Scholar
• Vadlamudi L, Milne RL, Lawrence K, Heron SE, et al. Genetics of epilepsy: the testimony of twins in the molecular era. Neurology. 2014;83(12):1042–1048.
   PubMed Web of Science ®Google Scholar
• Boyles JK, Pitas RE, Wilson E, et al. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985;76(4):1501–1513.
   PubMed Web of Science ®Google Scholar
• Gee JR, Keller JN. Astrocytes: regulation of brain homeostasis via apolipoprotein E. Int J Biochem Cell Biol. 2005;37:1145–1150.
   PubMed Web of Science ®Google Scholar
• Harris FM, Tesseur I, Brecht WJ, et al. Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease. J Biol Chem. 2004;279(5):3862–3868.
   PubMed Web of Science ®Google Scholar
• Gutman CR, Strittmatter WJ, Weisgraber KH, et al. Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor. J Neurosci. 1997;17(16):6114–6121.
   PubMed Web of Science ®Google Scholar
• Lee Y, Aono M, Laskowitz D, et al. Apolipoprotein E protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate toxicity. Neurochem Int. 2004;44(2):107–118.
   PubMed Web of Science ®Google Scholar
• Chapman J, Korczyn AD, Karussis DM, et al. The effects of APOE genotype on age at onset and progression of neurodegenerative diseases. Neurology. 2001;57(8):1482–1485.
   PubMed Web of Science ®Google Scholar
• Fazekas F, Strasser-Fuchs S, Kollegger H, et al. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology. 2001;57(5):853–857.
   PubMed Web of Science ®Google Scholar
• Gong JE, Qu J, Long HY, et al. Common variants of APOE are associated with anti-epileptic drugs resistance in Han Chinese patients. Int J Neurosci. 2017;127(1):14–19.
   PubMed Web of Science ®Google Scholar
• Sporis D, Sertic J, Henigsberg N, et al. Association of refractory complex partial seizures with a polymorphism of ApoE genotype. J Cell Mol Med. 2005;9:698–703.
   PubMed Web of Science ®Google Scholar
• Diaz-Arrastia R, Gong Y, Fair S, et al. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurol. 2003;60(6):818–822.
   PubMedGoogle Scholar
• Friedman G, Froom P, Sazbon L, et al. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology. 1999;52(2):244–248.
   PubMed Web of Science ®Google Scholar
• Li Z, Ding C, Gong X, et al. Apolipoprotein E epsilon4 allele was associated with nonlesional mesial temporal lobe epilepsy in Han Chinese population. Medicine. 2016;95(9):e2894.
   PubMed Web of Science ®Google Scholar
• Cavalleri GL, Lynch JM, Depondt C, et al. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here? Brain. 2005;128(8):1832–1840.
   PubMedGoogle Scholar
• Gambardella A, Aguglia U, Cittadella R, et al. Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia. 1999;40(12):1804–1807.
   PubMed Web of Science ®Google Scholar
• Yeni SN, Ozkara C, Buyru N, et al. Association between APOE polymorphisms and mesial temporal lobe epilepsy with hippocampal sclerosis. Eur J Neurol. 2005;12(2):103–107.
   PubMed Web of Science ®Google Scholar
• Briellmann RS, Torn-Broers Y, Busuttil BE, et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology. 2000;55(3):435–437.
   PubMed Web of Science ®Google Scholar
• Kauffman MA, Consalvo D, Moron DG, et al. ApoE epsilon4 genotype and the age at onset of temporal lobe epilepsy: a case-control study and meta-analysis. Epilepsy Res. 2010;90(3):234–239.
   PubMed Web of Science ®Google Scholar
• Salzmann A, Perroud N, Crespel A, et al. Candidate genes for temporal lobe epilepsy: a replication study. Neurol Sci. 2008;29:397–403.
   PubMed Web of Science ®Google Scholar
• Leal B, Chaves J, Carvalho C, et al. Age of onset of mesial temporal lobe epilepsy with hippocampal sclerosis: the effect of apolipoprotein E and febrile seizures. Int J Neurosci. 2017;127(9):800–804.
   PubMed Web of Science ®Google Scholar
• Busch RM, Lineweaver TT, Naugle RI, et al. ApoE-epsilon4 is associated with reduced memory in long-standing intractable temporal lobe epilepsy. Neurology. 2007;68(6):409–414.
   PubMed Web of Science ®Google Scholar
• Gambardella A, Aguglia U, Chifari R, et al. ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy. Epilepsia. 2005;46(1):110–117.
   PubMed Web of Science ®Google Scholar
• Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545–548.
   PubMed Web of Science ®Google Scholar
• Sporis D, Basic S, Sertic J, et al. Is apolipoprotein E epsilon2 associated with delayed onset of non-lesional temporal lobe epilepsy? Acta Clin Croat. 2017;56:10–14.
   PubMed Web of Science ®Google Scholar
• Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet. 1996;14(1):55–61.
   PubMed Web of Science ®Google Scholar
• Aboud O, Mrak RE, Boop FA, et al. Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype. Acta Neuropathol Commun. 2013;1(1):41.
   PubMedGoogle Scholar
• Keeney JT, Ibrahimi S, Zhao L. Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer's disease prevention and early intervention. J Alzheimer's Dis. 2015;48(2):411–424.
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang X, Zhao L. Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer's disease risk reduction and early intervention. J Neurosci. 2018;38(30):6665–6681.
   PubMed Web of Science ®Google Scholar
• Li YJ, Pericak-Vance MA, Haines JL, et al. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics. 2004;5(4):209–213.
   PubMed Web of Science ®Google Scholar
• Conejero-Goldberg C, Gomar JJ, Bobes-Bascaran T, et al. APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms. Mol Psychiatry. 2014;19(11):1243–1250.
   PubMed Web of Science ®Google Scholar
• Nagy Z, Esiri MM, Jobst KA, et al. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience. 1995;69(3):757–761.
   PubMed Web of Science ®Google Scholar